1
|
Das AK, Kalra S, B K, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, Gangadhar P, Dhingra A, Tiwaskar M, Shukla R, Das S, Baruah MP, Gangopadhyay KK, Ramakrishnan S, Deshmukh V, Dasgupta A, Kumar GV, Pandey N, Joshi A, Surana VK, Punyani H, Shah P, Rattan A, Chandrasekaran S, Asirwatham A. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion. Diabetes Metab Syndr 2021; 15:55-62. [PMID: 33310177 PMCID: PMC7677048 DOI: 10.1016/j.dsx.2020.11.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2020] [Revised: 11/12/2020] [Accepted: 11/14/2020] [Indexed: 11/24/2022]
Abstract
BACKGROUND AND AIMS The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment's (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. METHOD The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. RESULTS The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. CONCLUSION The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Ashok Kumar Das
- Department of Endocrinology & Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India.
| | - Sanjay Kalra
- Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
| | - Krishnakumar B
- Department of Cardiology, Government Medical College, Thiruvananthapuram, Kerala, India
| | - Kamal Sharma
- Department of Cardiology, U.N.Mehta Institute of Cardiology, B.J. Medical College, Civil Hospital, Ahmedabad, India
| | - Mathew John
- Department of Endocrinology, Providence Endocrine & Diabetes Specialty Centre, Thiruvananthapuram, India
| | - Tiny Nair
- Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India
| | - Shehla Shaikh
- Department of Endocrinology & Diabetes, Prince Aly Khan Hospital, Mumbai, India
| | - Deepak Khandelwal
- Department of Endocrinology, Dr. Khandelwal's Diabetes & Endocrinology Clinic, New Delhi, India
| | - Gagan Priya
- Department of Endocrinology, Fortis Hospital, Chandigarh, Punjab, India
| | - Deep Dutta
- Department of Endocrinology, Center for Endocrinology Diabetes Arthritis & Rheumatology (CEDAR) Superspeciality Clinic, New Delhi, India
| | | | - Atul Dhingra
- Department of Endocrinology, Gangaram Bansal Hospital, Rajasthan, India
| | - Mangesh Tiwaskar
- Department of Medicine, Shilpa Medical Research Centre, Mumbai, Maharashtra, India
| | - Rishi Shukla
- Department of Endocrinology, Regency Hospital, Kanpur, India
| | - Sambit Das
- Department of Endocrinology, Apollo Hospitals in Bhubaneswar, India
| | | | | | - Santosh Ramakrishnan
- Department of Endocrinology, Magna Centers for Obesity, Diabetes and Endocrinology, Hyderabad, India
| | - Vaishali Deshmukh
- Department of Endocrinology, Deshmukh Clinic and Research Centre, Pune, Maharashtra, India
| | - Arundhati Dasgupta
- Department of Endocrinology, Rudraksh Superspeciality Care, Siliguri, India
| | - GVijaya Kumar
- Department of Diabetology, Apollo Hospitals, Chennai, Tamil Nadu, India
| | - Neelam Pandey
- Department of Endocrinology, Max Hospital, Gurgaon, India
| | - Amya Joshi
- Department of Endocrinology & Diabetes, Bhaktivedanta Hospital and Research Institute, Mumbai, Maharashtra, India
| | | | - Hitesh Punyani
- Department of Medicine, Chaitanya Cardio Diabetes Centre, New Delhi, India
| | - Parag Shah
- Department of Endocrinology and Diabetes, Gujarat Endocrine Centre, Ahmedabad, India
| | - Aditya Rattan
- Department of Cardiology, Heart Line Hospital, Panchkula, Harayana, India
| | - Sruti Chandrasekaran
- Department of Endocrinology and Diabetes, Dr Rela Institute of Medical Science (RIMC), Chennai, Tamil Nadu, India
| | - Arthur Asirwatham
- Department of Diabetology, Arthur Asirvatham Hospital, Madurai, Tamil Nadu, India
| |
Collapse
|